Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biohealth Italia is an Italian pharmaceutical and nutraceutical company specializing in the development and commercialization of innovative mineral supplements and treatments for urinary health. Based in Rivoli, the company has established a leading position in the Italian market with a portfolio of well-known brands such as Lithos, Acidif, and Alkalos. Its products primarily target mineral metabolism and urinary tract conditions, including the prevention of kidney stones and the management of urinary discomfort. In 2021, Biohealth Italia was acquired by the French pharmaceutical group Mayoly Spindler to serve as a cornerstone for its European expansion strategy in the consumer healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biohealth.